Clinical Scorecard: UK Launches National Allergy Strategy

At a Glance

Key Highlights

• One in three people in the UK are affected by allergic diseases, with rising prevalence and hospital admissions.
• The strategy proposes a coordinated four-nation approach to improve prevention, diagnosis, treatment, and long-term management.
• Key priorities include reducing preventable harm, improving quality of life, addressing health inequalities, and building a sustainable allergy workforce.

Guideline-Based Recommendations

Diagnosis

• Improve access to specialist immunology services to meet clinical demand.
• Establish consistent standards of care and better coordination during transitions between services.

Management

• Embed allergy care into workforce planning and professional education.
• Strengthen community-based allergy services.
• Improve access to effective treatments and essential medicines.

Monitoring & Follow-up

• Create a national allergy register to support surveillance and service planning.
• Enhance national data collection on allergy prevalence and outcomes.

Risks

• Address preventable harm such as severe allergic reactions and anaphylaxis.
• Reduce health inequalities linked to geography and socioeconomic status.

Patient & Prescribing Data

Patients with allergic diseases attending general practice

Allergic diseases account for around 6% of GP visits and 10% of GP prescribing budget, indicating high treatment demand.

Clinical Best Practices

• Provide mandatory allergy training in schools and other public sectors to improve safety.
• Ensure protected time and resources for consultant immunologists to train and retain workforce.
• Coordinate multi-sectoral action across healthcare, education, food regulation, and workplace settings.

References

• National Allergy Strategy UK
• Royal College of Pathologists Immunology Specialty Advisory Committee statement